Aortic regurgitation pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
mNo edit summary
Line 34: Line 34:
* [[Giant cell arteritis]]
* [[Giant cell arteritis]]
* [[Syphilitic aortitis]]  
* [[Syphilitic aortitis]]  
* [[Behçet's syndrome]]
* Behçet's syndrome
* [[Ankylosing spondylitis]]
* [[Ankylosing spondylitis]]
* [[Psoriatic arthritis]]
* [[Psoriatic arthritis]]
Line 42: Line 42:
* [[Relapsing polychondritis]]
* [[Relapsing polychondritis]]
</div>
</div>


==Acute vs Chronic Causes==
==Acute vs Chronic Causes==
Line 68: Line 69:
* [[Ehlers-Danlos Syndrome]]
* [[Ehlers-Danlos Syndrome]]
* [[Marfan Syndrome]]
* [[Marfan Syndrome]]
* [[Bechterew's Disease]]
* Bechterew's Disease
* [[Rheumatoid Arthritis]]
* [[Rheumatoid Arthritis]]
* [[Ankylosing Spondylitis]]
* [[Ankylosing Spondylitis]]

Revision as of 14:48, 4 April 2011

WikiDoc Resources for Aortic regurgitation pathophysiology

Articles

Most recent articles on Aortic regurgitation pathophysiology

Most cited articles on Aortic regurgitation pathophysiology

Review articles on Aortic regurgitation pathophysiology

Articles on Aortic regurgitation pathophysiology in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Aortic regurgitation pathophysiology

Images of Aortic regurgitation pathophysiology

Photos of Aortic regurgitation pathophysiology

Podcasts & MP3s on Aortic regurgitation pathophysiology

Videos on Aortic regurgitation pathophysiology

Evidence Based Medicine

Cochrane Collaboration on Aortic regurgitation pathophysiology

Bandolier on Aortic regurgitation pathophysiology

TRIP on Aortic regurgitation pathophysiology

Clinical Trials

Ongoing Trials on Aortic regurgitation pathophysiology at Clinical Trials.gov

Trial results on Aortic regurgitation pathophysiology

Clinical Trials on Aortic regurgitation pathophysiology at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Aortic regurgitation pathophysiology

NICE Guidance on Aortic regurgitation pathophysiology

NHS PRODIGY Guidance

FDA on Aortic regurgitation pathophysiology

CDC on Aortic regurgitation pathophysiology

Books

Books on Aortic regurgitation pathophysiology

News

Aortic regurgitation pathophysiology in the news

Be alerted to news on Aortic regurgitation pathophysiology

News trends on Aortic regurgitation pathophysiology

Commentary

Blogs on Aortic regurgitation pathophysiology

Definitions

Definitions of Aortic regurgitation pathophysiology

Patient Resources / Community

Patient resources on Aortic regurgitation pathophysiology

Discussion groups on Aortic regurgitation pathophysiology

Patient Handouts on Aortic regurgitation pathophysiology

Directions to Hospitals Treating Aortic regurgitation pathophysiology

Risk calculators and risk factors for Aortic regurgitation pathophysiology

Healthcare Provider Resources

Symptoms of Aortic regurgitation pathophysiology

Causes & Risk Factors for Aortic regurgitation pathophysiology

Diagnostic studies for Aortic regurgitation pathophysiology

Treatment of Aortic regurgitation pathophysiology

Continuing Medical Education (CME)

CME Programs on Aortic regurgitation pathophysiology

International

Aortic regurgitation pathophysiology en Espanol

Aortic regurgitation pathophysiology en Francais

Business

Aortic regurgitation pathophysiology in the Marketplace

Patents on Aortic regurgitation pathophysiology

Experimental / Informatics

List of terms related to Aortic regurgitation pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-in-Chief: Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Aortic Valve vs Aortic Root Causes

Aortic Valve Disease

A full list of causes of aortic insufficiency can be found on the page dedicated to the Differential Diagnosis of Underlying Causes.

One of the most common causes of aortic valvular disease in the past has been rheumatic fever in which case the aortic cusps are infiltrated with fibrous tissue. This then leads to retraction of the cusps and prevents their apposition during diastole. The cusps may also fuse and this may cause a component of aortic stenosis. It is therefore not uncommon for these patients to have mixed aortic regurgitation and aortic stenosis. Often these patients will have involvement of the mitral valve as well.

In the modern era, a more common cause of acquired aortic valve regurgitation is degenerative disease of the aorta and aortic valve in which case there is calcification and fibrosis of the cusps. As is the case with rheumatic fever, there is similar retraction of the cusps that results in aortic insufficiency.

A third not uncommon cause of acquired aortic regurgitation is infective endocarditis. In this disease state, regurgitation develops as a result of a hole or perforation that develops in the leaflet, or alternatively the cusps may not oppose each other due to a vegetation lying between the cusps which prevents their apposition.

Drugs such as dopamine agonists cause activation of serotonin -2B receptors (located in aortic valve and mitral valve) resulting in stimulation of fibroblast growth and fibrogenesis, thereby causing aortic insufficiency[1][2][3].

A final not uncommon cause of acquired aortic insufficiency is following a blunt chest trauma or a deceleration injury which causes traumatic aortic valve rupture resulting in distortion of the valve architecture leading to failure of the cusps to oppose[4][5].

Congenital conditions such as congenital bicuspid aortic stenosis or a ventricular septal defect can also result in aortic insufficiency. Patients with bicuspid aortic valve are at increased risk of developing aortic dissection[6].

Aortic Root Disease

Aortic root disease as a cause of aortic insufficiency has overtaken acquired forms of valvular disease and congenital forms of valvular disease as the leading cause of aortic regurgitation. The following is a list of those conditions that lead to dilation of the aortic root and thereby cause aortic insufficiency:


Acute vs Chronic Causes

Acute Aortic Insufficiency

Chronic Aortic Insufficiency


Hemodynamic Consequences of Aortic Insufficiency

Acute aortic insufficiency

Acute aortic insufficiency is often secondary to infective endocarditis, aortic dissection[8] or traumatic aortic rupture[4][9].

In acute aortic insufficiency, there is sudden decrease in stroke volume secondary to regurgitation of blood into left ventricle with resultant sudden increase left ventricular end diastolic volume causing decreased stroke volume and cardiac output with subsequent cycles. The very high left ventricular end diastolic pressure and reflex tachycardia (due to decrease cardiac output) causes profound hypotension and cardiogenic shock.

Also the sharply rising left ventricular end diastolic pressure causes the mitral valve to close earlier during diastole. This early closure fortunately prevents backward flow of blood into the pulmonary vascular bed and often keeps the aortic diastolic pressure from falling too low and thus there is often not a wide pulse pressure. But in severe cases, the left ventricular end diastolic pressure equalizes with the aortic end-diastolic pressure leading to backward flow of blood causing elevation of left atrial and pulmonary venous pressures with resultant development of pulmonary edema. Indeed absence of a wide pulse pressure in the patient with acute aortic insufficiency should alert the clinician to potential left ventricular failure.


Chronic Aortic Insufficiency

In chronic aortic insufficiency, the aortic valve is unable to remain closed during diastole, which results in a portion of blood volume regurgitating into the left ventricle, thereby adding to the left ventricular end diastolic volume. Initially the heart adapts well to chronic aortic insufficiency as the left ventricle remains complaint. Therefore, the associated volume overload status is compensated by progressive left ventricular dilation and left ventricular hypertrophy, thereby increasing the stroke volume and cardiac output despite the regurgitant lesion.

In aortic insufficiency there is eccentric hypertrophy where in the sarcomers replicate in series and there is elongation of the myocytes and myocardial fibrils. As a result of this hypertrophy the ratio of the ventricular wall thickness to cavity radius remains normal and therefore wall stress is normal. In aortic stenosis there is concentric hypertrophy where in the sarcomers replicate in parallel.

Once wall thickening fails to keep up with the hemodynamic load, end systolic wall stress rises and at this point the left ventricle fails. The dramatic enlargement of the heart that is seen with aortic insufficiency is called cor bovinum. Over time the left ventricle will decompensate and there will be increasing interstitial fibrosis and stiffening causing reduction in the left ventricular wall compliance. At this point the patient will experience a rise in the left ventricular end diastolic volume and pressure. The first decline is seen with exercise and then the patient begins to have a reduction in forward output at rest.

Patients with chronic aortic insufficiency may also develop myocardial ischemia. This is due to the fact that they have an increase in demand due to an increased thickness of the left ventricle and also a reduction in the supply due to a lower perfusion pressure during diastole.

It has been said that 'aortic regurgitation begets aortic regurgitation'. The high oscillatory shear associated with aortic regurgitation may lead to further dilation of the aorta, which in turn may lead to further worsening of aortic regurgitation.

The mitral valve ring may also dilate leading to mitral regurgitation which further can progress to the development of left atrium dilatation.

References

  1. Waller EA, Kaplan J, Heckman MG (2005). "Valvular heart disease in patients taking pergolide". Mayo Clinic Proceedings. Mayo Clinic. 80 (8): 1016–20. PMID 16092580. Retrieved 2011-03-28. Unknown parameter |month= ignored (help)
  2. Rothman RB, Baumann MH, Savage JE, Rauser L, McBride A, Hufeisen SJ, Roth BL (2000). "Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications". Circulation. 102 (23): 2836–41. PMID 11104741. Retrieved 2011-03-28. Unknown parameter |month= ignored (help)
  3. Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E (2007). "Dopamine agonists and the risk of cardiac-valve regurgitation". The New England Journal of Medicine. 356 (1): 29–38. doi:10.1056/NEJMoa062222. PMID 17202453. Retrieved 2011-03-28. Unknown parameter |month= ignored (help)
  4. 4.0 4.1 Prêtre R, Faidutti B (1993). "Surgical management of aortic valve injury after nonpenetrating trauma". The Annals of Thoracic Surgery. 56 (6): 1426–31. PMID 8267458. Retrieved 2011-03-28. Unknown parameter |month= ignored (help)
  5. Onorati F, De Santo LS, Carozza A, De Feo M, Renzulli A, Cotrufo M (2004). "Marfan syndrome as a predisposing factor for traumatic aortic insufficiency". The Annals of Thoracic Surgery. 77 (6): 2192–4. doi:10.1016/S0003-4975(03)01409-7. PMID 15172299. Retrieved 2011-03-28. Unknown parameter |month= ignored (help)
  6. Fedak PW, Verma S, David TE, Leask RL, Weisel RD, Butany J (2002). "Clinical and pathophysiological implications of a bicuspid aortic valve". Circulation. 106 (8): 900–4. PMID 12186790. Retrieved 2011-03-28. Unknown parameter |month= ignored (help)
  7. 7.0 7.1 Isner JM (1991). "Acute catastrophic complications of balloon aortic valvuloplasty. The Mansfield Scientific Aortic Valvuloplasty Registry Investigators". Journal of the American College of Cardiology. 17 (6): 1436–44. PMID 2016464. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  8. Roberts WC, Ko JM, Moore TR, Jones WH (2006). "Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005)". Circulation. 114 (5): 422–9. doi:10.1161/CIRCULATIONAHA.106.622761. PMID 16864725. Retrieved 2011-03-28. Unknown parameter |month= ignored (help)
  9. Onorati F, De Santo LS, Carozza A, De Feo M, Renzulli A, Cotrufo M (2004). "Marfan syndrome as a predisposing factor for traumatic aortic insufficiency". The Annals of Thoracic Surgery. 77 (6): 2192–4. doi:10.1016/S0003-4975(03)01409-7. Retrieved 2011-03-28. Unknown parameter |month= ignored (help)

Template:WH Template:WS